ResearcherUmeå UniversityActive in the last 2 years
Roger Henriksson
Matched on ORCID iD 0000-0002-1467-9339; OpenAlex author ID A5001810357. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL). Co-author DOI 10.1177/02692163261437609↗
- Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL) Last author DOI 10.3238/arztebl.m2024.0080↗
- Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-bli… Co-author DOI 10.1186/s13063-020-04581-y↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kathrin Wode · 3 shared papers, 2020–2026 · strength 0.59
- Paper Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, random… DOI 10.1177/02692163261437609↗
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
- Nils O. Elander · 3 shared papers, 2020–2026 · strength 0.59
- Paper Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, random… DOI 10.1177/02692163261437609↗
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
- Gunver Sophia Kienle · 3 shared papers, 2020–2026 · strength 0.59
- Paper Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, random… DOI 10.1177/02692163261437609↗
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
- Lena Sharp · 3 shared papers, 2020–2026 · strength 0.59
- Paper Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, random… DOI 10.1177/02692163261437609↗
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
- Per Fransson · 3 shared papers, 2020–2026 · strength 0.59
- Paper Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, random… DOI 10.1177/02692163261437609↗
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
- Britt‐Marie Bernhardson · 2 shared papers, 2020–2024 · strength 0.31
- Paper Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MIS… DOI 10.3238/arztebl.m2024.0080↗
- Paper Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a… DOI 10.1186/s13063-020-04581-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.